Year: 2022
Type: editorial
Abstract: Coronary microvascular dysfunction (CMD) encompasses the range of structural and functional changes in the coronary microvasculature that cause diminished coronary blood flow and consequently myocardial ischemia.1 CMD may be the result of impaired vasodilatory capacity or increased coronary microvascular vasoconstriction. Structural impairments accompanying CMD are predominantly characterized by intramural arteriole and capillary luminal narrowing, perivascular fibrosis, and microvascular rarefaction, often associated with left ventricular muscle hypertrophy.
Source: Kidney International Reports
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,625
OpenAlex ID: W4309779738
